Hint mode is switched on Switch off
For swift navigation between sections

Ascelia Pharma
LEI 5493002YR9VCJJPWYN08

PDF download

Choose all Reset all
Download Cancel
Organization name
Ascelia Pharma AB
Country name
Sweden
Country of registration
-
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Ascelia Pharma AB is an oncology-dedicated drug development company located in Malmo, Sweden, focused on the development of novel drugs to improve the life expectancy and quality of life for people living with cancer. The company is focused on two clinical-stage product candidates under development: Mangoral and Oncoral.

Awards

Documentation

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    5493002YR9VCJJPWYN08
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • Organisationsnummer
    556571-8797
Registration is required to get access.